Screener
Kalaris Therapeutics KLRS Free cash flow
Discontinued — last reported Q4 '25
Free cash flow at other companies
Other financials
Where this comes from
Calculated from Kalaris Therapeutics’s reported figures.
The source filing: Kalaris Therapeutics’s 10-K, filed March 17, 2026. Open the filing →
- Filed
- Mar 17, 2026, 12:00 AM EDT
- Fiscal year
- FY2025
- Accession
- 0001193125-26-110659
FAQ
- What is Kalaris Therapeutics's free cash flow?
- Kalaris Therapeutics (KLRS) reported free cash flow of -$7.07M in Q4 2025.
- What does free cash flow mean?
- Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.
Ask your AI about Kalaris Therapeutics's free cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude